Vitalgen is committed to developing innovative cell and gene therapies for the treatment of blood and metabolic disorders, neurodegenerative diseases, retinal diseases and cancers.
Gene Therapy
Discovery
Optimization
IND-enabling
Clinical Stage
Gene Editing
Discovery
Optimization
IND-enabling
Clinical Stage
Note 1: Investigator Initiated Trials (IITs) ongoing
Note 2: Orphan Drug Designation; Rare Pediatric Disease Designation
Note 3:Over 10 programs in the early stage of development